Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by Boomskidon Aug 24, 2023 12:40am
216 Views
Post# 35603153

TT's Sappy Cap Plot

TT's Sappy Cap PlotIn his desperation, TT has come up with a thought that Ladenberg Thalmann employed destructive methods like Sabby Captial uses. 

There is no doubt that LT's efforts were destructive. BTI is trading at half a penny.

The problem for him is that he can't give up the argument that xB3 is no good.

I have asked him to tell us what Ladenberg Thalmann and their clients were going to get out of the deal if it wasn't xB3?

What was it they wanted? What was their play?

He's saying that they were milking us (me, and you shareholders) for everything they could get.

Was LT paid anything by Bioasis? Cash? Bioasis had/has no money. Or were they going to be paid in stock and warrants if a deal got done?

TT won't let the facts get in front of his hate for me.

He's looking more and more like a hateful hack, a troll.

What LT got and was going to get are detailed in the 460-page Bioasis filing and Midatech's filings.

But he knows better than the facts. Besides, there is little in the 460 pages that he can comprehend, I suspect. 

But, he raised it like he knows better so I'll keep on asking him.

If xB3 is no good, then what were Midatech, LT, The Placee, DrDR and Brother Mario going to get out of the deal if it wasn't a worthless xB3?

Simple question. He raised it.

jd
<< Previous
Bullboard Posts
Next >>